Nadifloxacin

那氟沙星

Report date: 2026/03/04 20:01:44
NME

Base Information

Drug NameNadifloxacin
Drug Alias Name那地沙星NadifloxacinoNadifloxacinumNadifloxacineNadoxin +[8] 
ClassificationSmall molecules > Heterocyclic drugs > Antibiotics > Quinolone antibiotics
Mechanisms of ActionBacterial DNA gyrase inhibitorsTopoisomerase IV inhibitors
TargetsTopoisomerase IVBacterial DNA gyrase
Therapy Area/IndicationsFolliculitisAcne VulgarisAbscess +[4] 
Global Approved IndicationsFolliculitisAcne VulgarisAbscess +[4] 
Approved Indications in ChinaFolliculitisAcne VulgarisAbscess
Original Approved Country/TerritoryJapan
Original Approved Date1993/09/01
Country/TerritoryEUMainland ChinaJapan
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesOtsuka Pharmaceutical Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesFerrer Internacional SaOtsuka Pharmaceuticals
Inactive CompaniesN/A
Active IndicationsFolliculitisAcne VulgarisAbscess +[4] 
Inactive IndicationsN/A

Other Information

ATC CodeD10AF05
Related LinksWikipediaKEGG